Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kelemen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 1998
Intravascular magnetic resonance imaging of aortic atherosclerotic plaque compositionL C Correia, E Atalar, M D Kelemen, et al.
Neuroscience|May 19, 2007
P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitroR Benkó, S Undi, M Wolf, et al.
The Journal of Biological Chemistry|November 21, 2022
Impact of inherent biases built into proteomic techniques: Proximity labeling and affinity capture comparedClaudia Maria do Nascimento Moreira, Cristina D Kelemen, Samson O Obado, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Development of an observational tool on computer use during roundsDanny Ho, Yan Xiao, Ayan Sen, et al.
Molecular Cancer Therapeutics|November 3, 2021
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell LymphomasMagdalena Klanova, Dmitry Kazantsev, Eva Pokorna, et al.
American Journal of Hypertension|April 6, 2004
Exaggerated exercise blood pressure is related to impaired endothelial vasodilator functionKerry J Stewart, Jidong Sung, Harry A Silber, et al.
JAMA|January 5, 2006
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trialSteven P Schulman, Lewis C Becker, David A Kass, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics ProgramAlan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 23, 1998
Intravascular magnetic resonance imaging of aortic atherosclerotic plaque compositionL C Correia, E Atalar, M D Kelemen, et al.
Neuroscience|May 19, 2007
P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitroR Benkó, S Undi, M Wolf, et al.
The Journal of Biological Chemistry|November 21, 2022
Impact of inherent biases built into proteomic techniques: Proximity labeling and affinity capture comparedClaudia Maria do Nascimento Moreira, Cristina D Kelemen, Samson O Obado, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Development of an observational tool on computer use during roundsDanny Ho, Yan Xiao, Ayan Sen, et al.
Molecular Cancer Therapeutics|November 3, 2021
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell LymphomasMagdalena Klanova, Dmitry Kazantsev, Eva Pokorna, et al.
American Journal of Hypertension|April 6, 2004
Exaggerated exercise blood pressure is related to impaired endothelial vasodilator functionKerry J Stewart, Jidong Sung, Harry A Silber, et al.
JAMA|January 5, 2006
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trialSteven P Schulman, Lewis C Becker, David A Kass, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 12, 2014
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics ProgramAlan R Shuldiner, Kathleen Palmer, Ruth E Pakyz, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
Clinical Pharmacology and Therapeutics|April 17, 2013
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementationA R Shuldiner, M V Relling, J F Peterson, et al.
Pageof 4